Portfolio of Genetic Testing Stocks
Here are 7 genetic testing stocks.
| 7 Genetic Testing Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Cancer Genetics | CGIX | |
| Exact Sciences | EXAS | |
| Genetic Technologies Ltd | GENE | |
| HTG Molecular Diagnostics | HTGM | |
| Invitae | NVTA | |
| Natera | NTRA | |
| Veracyte | VCYT | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
Portfolio Values
To inspect the performance of the Genetic Testing Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 7 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.The current value of the $10,000 investment is $10,538. The percent return is 5.38%. The annualized return is 1.05%.
| 7 Genetic Testing Stocks Returns | ||
|---|---|---|
Name | Symbol | % Return & Details |
| Cancer Genetics | CGIX | -99.23% |
| Exact Sciences | EXAS | 11.37% |
| Genetic Technologies Ltd | GENE | -67.81% |
| HTG Molecular Diagnostics | HTGM | -97.42% |
| Invitae | NVTA | -74.48% |
| Natera | NTRA | 226.34% |
| Veracyte | VCYT | 138.90% |
Portfolio Value Chart for Last 100 Daily Closes